Aminologics Co.,Ltd. (KOSDAQ:074430)
South Korea · Delayed Price · Currency is KRW 1,008.00
-13.00 (-1.27%)
At close: Nov 3, 2026
Aminologics Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 26,158 | 22,020 | 16,790 | 20,887 | 27,337 | 22,849 |
Revenue Growth | 64.47% | 31.15% | -19.61% | -23.60% | 19.64% | 29.45% |
Gross Profit Gross Profit Growth | 12,369 | 9,832 | 3,384 | 7,734 | 12,790 | 9,128 |
Operating Income Operating Income Growth | 5,479 | 3,594 | -2,153 | 1,462 | 6,908 | 3,953 |
Net Income Net Income Growth | 3,159 | 3,522 | -1,620 | 2,436 | -7,282 | 5,360 |
Earnings Per Share EPS Growth | 35.97 | 40.10 | -18.45 | 27.74 | -82.91 | 61.03 |
EPS Growth | - | - | - | - | - | 150.46% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Amino Acid Amino Acid Growth | 22,013 | 17,689 | 11,478 | 16,183 | 17,730 | 8,548 |
Raw Drug Product Raw Drug Product Growth | 4,145 | 4,331 | 5,312 | 4,703 | 9,607 | 14,301 |
Total Total Growth | 26,158 | 22,020 | 16,790 | 20,887 | 27,337 | 22,849 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 53,239 | 63,032 | 35,382 | 28,499 | 29,238 | 25,663 |
Total Debt Total Debt Growth | 16,845 | 16,214 | 2,018 | 1,819 | 1,989 | 1,654 |
Net Cash (Debt) Net Cash Growth | 36,395 | 46,817 | 33,364 | 26,680 | 27,249 | 24,010 |
Net Cash Growth | 21.34% | 40.32% | 25.05% | -2.09% | 13.49% | 1.29% |
Net Cash Per Share Net Cash Per Share Growth | 414.39 | 533.07 | 379.88 | 303.78 | 310.26 | 273.38 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,764 | 2,541 | 7,466 | -218.15 | 5,226 | 935.52 |
Capital Expenditures CapEx Growth | -75.7 | -45.7 | -511.5 | -155.8 | -490.2 | -515.71 |
Free Cash Flow Free Cash Flow Growth | 1,688 | 2,495 | 6,955 | -373.95 | 4,736 | 419.81 |
Free Cash Flow Growth | -73.83% | -64.13% | - | - | 1028.11% | -71.24% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.29% | 44.65% | 20.16% | 37.03% | 46.79% | 39.95% |
Operating Margin | 20.95% | 16.32% | -12.82% | 7.00% | 25.27% | 17.30% |
Pretax Margin | 17.90% | 15.96% | -6.58% | 10.97% | -22.98% | 16.21% |
Profit Margin | 12.08% | 15.99% | -9.65% | 11.66% | -26.64% | 23.46% |
FCF Margin | 6.45% | 11.33% | 41.42% | -1.79% | 17.32% | 1.84% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.02 | 29.78 | - | 48.45 | - | 35.97 |
P/FCF Ratio | 52.63 | 42.03 | 11.34 | - | 33.94 | 459.21 |
PS Ratio | 3.40 | 4.76 | 4.70 | 5.65 | 5.88 | 8.44 |